Skip to search.
 BSE Up0.12% NSE Up0.15%

Gilead Sciences Inc. (GILD)

-NasdaqGS

51.70 Down 0.24(0.46%) 11:15PM - Nasdaq Real Time Price

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period Ending31-Mar-201331-Dec-201230-Sep-201230-Jun-2012
Total Revenue 2,531,635   2,588,285   2,426,597   2,405,186  
Cost of Revenue634,448  675,818  597,269  617,345  
Gross Profit 1,897,187   1,912,467   1,829,328   1,787,841  
Operating Expenses
Research Development497,632  439,659  465,831  396,244  
Selling General and Administrative374,296  365,825  319,583  332,505  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss 1,025,259   1,106,983   1,043,914   1,059,092  
Income from Continuing Operations
Total Other Income/Expenses Net(3,324)1,386  (3,505)(1,075)
Earnings Before Interest And Taxes1,021,935  1,108,369  1,040,409  1,058,017  
Interest Expense81,787  85,906  89,322  88,418  
Income Before Tax940,148  1,022,463  951,087  969,599  
Income Tax Expense222,438  263,504  280,052  263,525  
Minority Interest4,476  3,582  4,470  5,490  
Net Income From Continuing Ops722,186  762,541  675,505  711,564  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 722,186   762,541   675,505   711,564  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 722,186   762,541   675,505   711,564  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.